202 related articles for article (PubMed ID: 33163928)
41. Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma-unique pathological features of the primary specimen: A case report.
Hori K; Hirohashi Y; Aoyagi T; Taniguchi N; Murakumo M; Miyata H; Torigoe T; Abe T; Shinohara N; Morita K
Exp Ther Med; 2020 Mar; 19(3):1903-1907. PubMed ID: 32104247
[TBL] [Abstract][Full Text] [Related]
42. Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report.
Mizutani K; Horie K; Nagai S; Tsuchiya T; Saigo C; Kobayashi K; Miyazaki T; Deguchi T
Mol Clin Oncol; 2017 Dec; 7(6):988-990. PubMed ID: 29285361
[TBL] [Abstract][Full Text] [Related]
43. [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].
Hattahara K; Yamasaki T; Sawada A; Tanigaki K; Endo S; Teramoto Y; Banno H; Fuchigami Y; Suzuki R; Fujiwara M; Hida T; Yoshino T; Kita Y; Goto T; Akamatsu S; Saito R; Kobayashi T; Inoue T; Ogawa O
Hinyokika Kiyo; 2019 May; 65(5):157-161. PubMed ID: 31247693
[TBL] [Abstract][Full Text] [Related]
44. Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report.
Machida A; Ikarashi D; Yanagawa N; Suzuki M; Kawamura T; Sekiguchi K; Takahashi K; Kato R; Matsura T; Maekawa S; Kanehira M; Takata R; Sugai T; Obara W
Cancer Diagn Progn; 2023; 3(1):124-129. PubMed ID: 36632579
[TBL] [Abstract][Full Text] [Related]
45. Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Urushibara M; Ishizaka K; Matsutani N; Takahashi M; Nagata M; Okumura T; Matsumoto Y; Tatsuoka S; Nenohi T; Amemiya T; Shimizu Y; Shirakawa T; Kato D
World J Surg Oncol; 2023 Feb; 21(1):37. PubMed ID: 36747242
[TBL] [Abstract][Full Text] [Related]
46. Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer.
Jun C; Yamauchi S; Yube Y; Egawa H; Yoshimoto Y; Kubota A; Tsuda K; Kaji S; Orita H; Oka S; Mine S; Fukunaga T
Surg Case Rep; 2023 May; 9(1):86. PubMed ID: 37204618
[TBL] [Abstract][Full Text] [Related]
47. [Renal Cancer Tissue after Nivolumab/Ipilimumab Combination Therapy for Metastatic Renal Cell Carcinoma].
Okuno Y; Tanaka R; Mikami K; Takeuchi T
Hinyokika Kiyo; 2020 Jan; 66(1):13-17. PubMed ID: 32028750
[TBL] [Abstract][Full Text] [Related]
48. Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma.
Singla N; Elias R; Ghandour RA; Freifeld Y; Bowman IA; Rapoport L; Enikeev M; Lohrey J; Woldu SL; Gahan JC; Bagrodia A; Brugarolas J; Hammers HJ; Margulis V
Urol Oncol; 2019 Dec; 37(12):924-931. PubMed ID: 31522865
[TBL] [Abstract][Full Text] [Related]
49. [A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy].
Toyoshima M; Ikarashi D; Tsuboi H; Moriwaka M; Tamada S; Matsuura T; Maekawa S; Kato R; Kanehira M; Takata R; Sugimura J; Obara W
Hinyokika Kiyo; 2023 Aug; 69(8):227-232. PubMed ID: 37667600
[TBL] [Abstract][Full Text] [Related]
50. Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide-based vaccine.
Kurahashi R; Motoshima T; Fukushima Y; Murakami Y; Yatsuda J; Yamaguchi T; Sugiyama Y; Fukushima S; Komohara Y; Suekane S; Kamba T
IJU Case Rep; 2020 Mar; 3(2):44-48. PubMed ID: 32743467
[TBL] [Abstract][Full Text] [Related]
51. Bilateral adrenal metastasis of renal cell carcinoma 4 years after radical nephrectomy: A case report and review of literature.
Li Y; Ji Z; Wang D; Xie Y
Medicine (Baltimore); 2021 Aug; 100(31):e26838. PubMed ID: 34397852
[TBL] [Abstract][Full Text] [Related]
52. Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma.
Tanriverdi O; Ates S; Sandal KK; Uylas S; Bosna IC; Alkan A
J Oncol Pharm Pract; 2020 Oct; 26(7):1765-1768. PubMed ID: 32164490
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab.
Tachibana H; Ishiyama Y; Yoshino M; Yamashita K; Toki D; Kondo T
In Vivo; 2021; 35(3):1743-1747. PubMed ID: 33910858
[TBL] [Abstract][Full Text] [Related]
54. [Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report].
Sasagawa H; Numakura K; Nakamura G; Kukimoto T; Kikuchi A; Sagehashi R; Yamamoto R; Koizumi A; Nara T; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Habuchi T
Hinyokika Kiyo; 2021 Dec; 67(12):525-528. PubMed ID: 34991292
[TBL] [Abstract][Full Text] [Related]
55. [A Case of Progressive Sarcomatoid Renal Cell Carcinoma Treated with Second-Line Nivolumab after Surgery].
Hayakawa S; Nakagami H; Nakamura W; Fujisawa T; Kasahara M; Sasaki H; Shiroki R
Hinyokika Kiyo; 2020 Aug; 66(8):265-268. PubMed ID: 32882123
[TBL] [Abstract][Full Text] [Related]
56. Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma.
Shields LBE; Alsorogi MS; Mar N; Rezazadeh Kalebasty A
Case Rep Oncol; 2021; 14(2):1051-1058. PubMed ID: 34326741
[TBL] [Abstract][Full Text] [Related]
57. [INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].
Ishii M; Takezawa K; Imamura R; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Nonomura N
Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):109-112. PubMed ID: 35444079
[TBL] [Abstract][Full Text] [Related]
58. Histological complete response with nivolumab for renal cell carcinoma with multiple metastases: A case report.
Shirotake S; Kaneko G; Nagata K; Oyama M; Nishimoto K
Mol Clin Oncol; 2019 Feb; 10(2):244-248. PubMed ID: 30680202
[TBL] [Abstract][Full Text] [Related]
59. Safe administration of ipilimumab plus nivolumab to a dialysis patient with renal cell carcinoma.
Iwaki T; Niimi A; Kano M; Kurokawa Y; Yoshizaki U; Nozaki K; Nomiya A; Miyazaki H; Kume H
IJU Case Rep; 2021 Jan; 4(1):32-35. PubMed ID: 33426493
[TBL] [Abstract][Full Text] [Related]
60. [A CASE OF RENAL CELL CARCINOMA WITH SMALL INTESTINE METASTASIS DURING NIVOLUMAB PLUS IPILIMUMAB].
Karibe Y; Tabei T; Hayashi H; Sugimura R; Takizawa H; Terao H; Funahashi M; Ota J; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 2022; 113(3):110-114. PubMed ID: 37468276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
